3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
81
Colorectal Neoplasms
39
Stomach Neoplasms
17
Carcinoma, Non-Small-Cell Lung
15
Liver Neoplasms
14
Neoplasms
11
Melanoma
11
Carcinoma, Renal Cell
11
Esophageal Neoplasms
10
Pancreatic Neoplasms
9
Carcinoma, Transitional Cell
8
Breast Neoplasms
8
Uterine Cervical Neoplasms
7
Triple Negative Breast Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
7
Small Cell Lung Carcinoma
7
Ovarian Neoplasms
7
Head and Neck Neoplasms
7
Cholangiocarcinoma
7
Rectal Neoplasms
6
Neoplasm Metastasis
6
Colonic Neoplasms
6
Urinary Bladder Neoplasms
5
Gastrointestinal Neoplasms
5
Carcinoma, Merkel Cell
5
Biliary Tract Neoplasms
5
Prostatic Neoplasms
4
Sarcoma
3
Lung Neoplasms
3
Gallbladder Neoplasms
3
Interventions
Blood Specimen Collection
6
Magnetic Resonance Spectroscopy
4
Tenofovir
3
Liver Transplantation
3
Specimen Handling
2
Sorafenib
2
Simvastatin
2
tremelimumab
1
sonidegib
1
sofosbuvir-velpatasvir drug combination
1
peginterferon alfa-2a
1
navitoclax
1
maltodextrin
1
hepatitis B hyperimmune globulin
1
durvalumab
1
contrast agent BR1
1
bavituximab
1
atezolizumab
1
apixaban
1
adefovir dipivoxil
1
Viusid
1
Vitamin D
1
User-Centered Design
1
Surveys and Questionnaires
1
Sunitinib
1
Spermine Synthase
1
Sonazoid
1
Sampling Studies
1
Radiotherapy
1
Radiofrequency Ablation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fibrosis
×
atezolizumab
×
Gastrointestinal
×
Clear all
NCT06096779
2026-06-01
Kirros
Genentech, Inc.
Phase 2
Recruiting
30 enrolled